KALLO Inc.

a)  

Appointment: Kallo hereby conditionally appoints Agent as a Sales Agent, and Agent accepts in accordance with the provisions of this Agreement the terms of the Kallo Sales Agent Program.

b)  

Responsibilities: Responsibilities of the Agent (PDMS and Gateway) are defined in Schedule C. Failure to comply with this will be considered a material breach of this agreement. This also includes responsibilities for Kallo and the project management entity (BASCIC) appointed jointly by Kallo and the Agent.

c)  

Certified Sales Agent: Agent accepts and acknowledges that the Kallo 3 day Sales and 5 day Technical Training Program is required to be completed by the Agent within 90 days of execution of this agreement. Agent is required to pay a Training program fee of $10,000.00 for the Kallo Mobile care suite of Products on or before the date of execution of this agreement for the Authorization of Agent under this agreement by Kallo. Agent shall pay $1000/- per day for any additional days of training requested by Agent and all travel expenses plus per diem for the Kallo representative instructing the program will be due and payable to Kallo on or before execution of this agreement.   Certification is mandatory for Agent to become certified to represent the Kallo Mobile care suite of products licensed under this agreement and to benefit from commissions allocated to Agent as outlined in Schedule A of this agreement. Non-compliance of this Section (2), subparagraph (c) on the part of the Agent will automatically void this agreement.

d)  

All sales made by the Agent of the Kallo Mobile care suite of products shall create a Book of Business owned by the Agent, which constitutes all funds due to Agent under this agreement flowing from each sale for a period not to exceed 36 months from the date of acceptance by Kallo of the Client EULA or until the EULA terminates under the provision that are outlined therein of the Kallo Mobile care suite of products.

e)  

Agent is required bi-monthly to report all prospects, sales activity, activity reported on Kallo provided leads, and any current client

f)  

Exclusivity of territory (Nigeria): Agent’s appointment shall be exclusive for the Kallo Mobile care suite of products and services marked in Schedule A to this Agreement. Such appointment constitutes a grant of specific territory of Nigeria. Exclusivity is granted for the region of Nigeria, The Agent is expected to confirm the first purchase order as per Schedule D with the down payment within thee (3) months of execution of this agreement and in order to retain the exclusivity of the territory the Agent shall achieve the target commitment in Schedule D.

g)  

Agent shall be supplied with marketing material at no cost to agent in electronic format only. Print and mail expense are the responsibility of the Agent. Web design services, press release services, trade show design services, marketing content services, and listing services are provided at no cost to Agent as it relates to the Kallo Mobile care suite of products

Marketing and Sales Plan: The Agent shall prior to the signing of this agreement submit and have approved by Kallo a Marketing and Sales Plan for no less than 3 years committing the sale of no less than 15 Mobile Medical Clinics, 5 Mobile Clinics in twelve month period following the signing of this agreement as referred to in Schedule D, with minimum growth per annum thereafter of 20% cumulative. Failure to do this will be considered a material breach of this agreement.

i)  

Kallo shall not change the marketing and sales plan during this agreement without first discussing it with Agent and in the event that mutual agreement cannot be reached will provide at least 12 months' notice of any such change. Should agreement not be reached, Agent may maintain its existing "book of business" and cease making sales under this agreement without prejudice so

j)  

Competence: Agent agrees to comply in full with Section (2). Subparagraph (c) of this agreement and provide and acquire appropriate staffing, training and any other requirements for the marketing, and sales of the Kallo Mobile care suite of products, and to comply with the Kallo training, support, shipping and payment terms.

k)  

Conduct: Agent shall undertake no acts injurious to the business or goodwill of Kallo. Agent shall use its best efforts to promote Kallo and its products and service and shall promptly report and follow up all leads provided. Agent may not offer or promote competitive products without the consent of Kallo.

l)  

Independent Entities: Notwithstanding the use of the designation "Sales Agent". Agent is an independent contractor and shall at no time have the power

i.  

to bind Kallo;

ii.  

to alter or change any terms, conditions, warranties or covenants made by Kallo or

iii.  

to create in favor of any person any rights, which Kallo  has not previously  agreed in writing.

m)  

Form of Relationship: The relationship under this Agreement shall not create any legal partnership, franchise relationship, agency or other form of legal association between the parties, which would impose a liability of one party upon the other.

n)  

Insurance:  Agent   or   its   successors   shall   maintain   during   the   term   of   this Agreement and while it is still responsible for its Book of Business:

i.  

All required   workers' compensation or similar insurance;

ii.  

Comprehensive general liability insurance. Agent shall promptly supply Kallo with proof of such insurance upon request. Kallo shall maintain comprehensive general liability and errors and omissions insurance for the Kallo Mobile care suite of products. Kallo shall promptly supply Agent with proof of such insurance upon request.

o)  

Records: Agent shall supply to Kallo the full business data of each customer as a qualified prospect and at the time of sale and shall, during this Agreement and while it is still responsible for its

p)  

Sub-Agents: Agent shall not be permitted to establish sub-Agents without the express written consent of Kallo.

q)  

Corrupt Practices:  Agent represents that it will not make any payment or transfer anything of value, directly or indirectly, to any government official or employee; to any officer, director, employee, or representative, or Agent of any actual or potential customer; or to any other person or entity if such payments would violate applicable laws.

r)  

Prospects: Agent will provide Kallo with a list of active prospects on a regular basis as outlined in Section (2) Subparagraph (e) of this agreement. Kallo will use its best efforts to protect these prospects from being solicited by its other Agents or distributors, and to refrain from solicitation directly by Kallo, while taking into account prospect's wishes, and in as much as allowed by applicable laws. Agent in return agrees to respect active prospect lists of Kallo’s other Agents. For the above purposes, the Agent at least once every six (6) weeks and where details of each such contact are logged with Kallo define an active prospect as a prospect that is contacted.

a)  

Kallo represents and warrants to Agent that;

i.  

it has sufficient right, title and interest in and to the Kallo Mobile care suite of products to enter into this Agreement; and

ii.  

all Kallo Mobile care suite of products distributed to Agent is free and clear of all liens.

b)  

Kallo Mobile care suite of products’ Warranties Agent's exclusive warranty regarding the Kallo Mobile care suite of products is set forth in the applicable EULA provided with the Kallo Mobile care suite of products.

c)  

Except as stated above, Kallo makes no other warranties regarding the Kallo mobile care suite of products and documentation, and   any   services   provided   by Kallo including, without limitation, express or implied warranties, and expressly disclaims the   warranties   of   fitness for a particular purpose or merchantability, and any other warranty, express or implied.

d)  

In no event shall Kallo be liable for indirect, consequential, or incidental damages (including damages for loss of business profits, business interruption, loss of business information, and the like) arising out of the relationship between Kallo and Agent even if it has been advised of the possibility of such damages.

e)  

Kallo's cumulative liability under this agreement, including any cause of action in contract, tort or strict liability, shall be limited to the license fees paid by agent during the 12 months prior to such event.  Kallo's limitation of liability is cumulative with all Kallo’s expenditures to address liability being aggregated to determine satisfaction of the limit. Agent releases Kallo from all obligations, liabilities, claims or demands in excess of the limitation. The parties acknowledge that other parts of this agreement rely upon the inclusion of this section and the resulting allocation of risks.

f)  

Agent Actions: Kallo shall have no obligation to any party under any warranty given by Agent, its Agents or employees. Agent shall not make any representation or warranty with respect to the Kallo Mobile care suite of products other than those stated by Kallo in its written warranty, documentation and literature.

g)  

Agent Indemnification: Agent agrees to indemnify Kallo and to hold it harmless from and against any loss, damage, claims or demands whatsoever arising out of Agent's activities that are outside the scope of the EULA provided by Kallo to the end user regarding use of Kallo Mobile care suite of products. Kallo makes its representations and warrants to the end user and limits

h)  

Complaints: Agent shall make all reasonable efforts to handle all incidents of customer complaints or demands regarding the Kallo Mobile care suite of products and shall report promptly to Kallo all such incidents.

i)  

Kallo indemnification: Kallo agrees to indemnify Agent and to hold it harmless from and against any loss, damage, claims or demands whatsoever arising out of:

i.  

Intellectual property infringement arising from the Kallo Suite of Products;

ii.  

Breach of implied warranty or negligence.

iii.  

Activities that are outside the scope of the EULA provided by Kallo and issued to the customer through Agent regarding the use of the Kallo Mobile care suite of products. Kallo further agrees to indemnify AGENT and to hold it harmless from and against any loss, damage, claims, or demands whatsoever arising out of Kallo's activities that are outside the scope of this Agreement.

i.  

is in public domain at the time of disclosure,

ii.  

has been released by the other party without restrictions,

iii.  

has been lawfully obtained  by  the  disclosing  party  from  a  third  party  under  no  obligation  of confidentiality, or

iv.  

is independently developed by employees of the disclosing party without access to the confidential information.

a)  

Definition: "Trademarks" means any and all current or future company names, product names, marks, logos, designs, trade dress and other designations or brands used by Kallo in connection with its products and services and all marks similar thereto.

b)  

License: Kallo grants Agent the right to use the Trademarks solely for the purpose of distributing and marketing the Kallo Mobile care suite of products provided that Agent:

i.  

uses the appropriate Trademarks for the corresponding Kallo Mobile care suite of products;

ii.  

Identifies all Trademarks are registered trademarks of Kallo;

iii.  

take reasonable  steps  to  modify  all  objectionable  uses  of  the  Trademarks.

c)  

Ownership: Agent acknowledges that Kallo is the sole owner of the Trademarks and nothing herein shall grant to Agent any right or interest in the Trademarks. Agent shall not register, or attempt to register, any Trademarks or any marks confusingly similar thereto in any jurisdiction.

d)  

Limitations: Except as stated above, Agent is granted no right, title, license or interest in the Trademarks. Agent acknowledges Kallo’s rights in the Trademarks and agrees that any and all use of Trademarks by Agent shall inure to the sole benefit of Kallo. Agent agrees that it shall take no action inconsistent with Kallo ownership of the Trademarks and agrees not to challenge Kallo’s rights in or attempt to register any of the Trademarks, or any other name or mark owned or used by Kallo or any mark confusingly similar thereto.

e)  

Notification: Agent shall promptly notify Kallo of any use by any third party of Trademarks or any use by such third parties of

f)  

Co-Branding: Kallo agrees for co-branding needs with local government and sponsors logo. This is subject to:

i.  

The submission to and approval by Kallo of the recommended Logo I Product Name. This is to ensure that the overall look and feel of the Kallo Mobile care product is maintained.

ii.  

The supply of the Logo I Product Name in suitable high quality format allowing sufficient time as defined by Kallo to incorporate co-branding logo on the Mobile clinics.

iii.  

Kallo agreeing to this will, in no way reduce, undermine, alter or limit their rights as outlined in section 5 and 6 of this agreement.

Ownership: Agent understands and agrees that Agent takes title only to the media on which the Kallo Mobile care suite of products is provided. Title in and ownership of all copies of Kallo products and documentation, Trademarks and all property rights therein, shall remain at all times vested in Kallo. Agent acknowledges that the Kallo Mobile care suite of products is protected by domestic and international copyright and other forms of proprietary rights and agrees not to copy or otherwise reproduce (except as required for distribution to customers), modify, adapt, translate, reverse engineer, decompile, disassemble or create derivative works based on the Kallo Mobile care suite of products or the documentation.

b)  

No Rights Granted:  No provision in this Agreement shall be interpreted as an assignment or grant to Agent of any right, title or interest in the Kallo Mobile care suite of products, documentation or Trademarks.

c)  

Protection: Agent agrees to take any reasonable step necessary to protect the proprietary rights of Kallo and its

d)  

Copyright Notice: Agent agrees not to remove and shall reproduce and include all copyright notices or confidential or proprietary legends in and on all copies of Kallo Mobile care suite of products or documentation.

e)  

Breach: Agent understands and agrees that the protection of Kallo rights in and to the Kallo Mobile care suite of products, documentation and Trademarks and the prevention of any unauthorized copying, reproduction, modification, adaptation, translation, reverse engineering, de-compilation, disassembly and creation of derivative works, is of the essence of this Agreement and that any failure on its part, however minor, to discharge its obligations shall constitute a material breach of this Agreement.

a)  

Term: This Agreement shall enter into effect on the date it is signed by both parties as shown below.

b)  

Termination: This agreement shall terminate:

i.  

upon notification of a  Material Breach that is not cured within 10 business days thereafter;

ii.  

Failure to cure a non-material breach within sixty days of written notice;

iii.  

Automatically, unless otherwise agreed between parties, in the event that Agent is the subject of a proceeding in bankruptcy which is not dismissed within 60 days, is placed in receivership, or makes an assignment for the benefit of its creditors; or by

iv.  

Termination for "Cause" by giving 3 months written notice by the Agent or Kallo.  If given by Kallo, "Cause" shall be defined as non-performance on the part of the Agent by failing to make sufficient efforts to market the Kallo Mobile care suite of products.  Should the parties disagree as to what constitutes "sufficient marketing efforts", the issue will be submitted to binding arbitration.  This course of action is not intended to be a means for

c)  

On Termination:  Notwithstanding any terms of this agreement to the contrary, upon termination of this Agreement for any reason whatsoever, Kallo, unless otherwise agreed, shall set aside the Agent's Book of Business to be held by Kallo.

i.  

The revenue stream defined by the Book of Business at the time Kallo becomes the controlling party will remain constant except in as far as any elected reduction in use by its customers. Any increase in use will not be to the benefit of the Book of Business.

ii.  

Kallo shall pay over all funds collected from the Book of Business and due to Agent, less a reasonable administration fee to be assessed and determined by Kallo, to Agent or its designees or assigns immediately upon receipt and act as a conduit for Agent funds, except in as far as Kallo or its assignees are required to support customers in the Book of Business in which case the cost of providing such support, will be reasonably assessed and appropriate deductions made before passing the balance to Agent. In the event Agent does not agree with the costs described in this section, the issue will be submitted to binding arbitration.

iii.  

Kallo shall make an accounting of funds collected to Agent or their assigns monthly. Kallo shall permit Agent or its designated Agent(s) to inspect Kallo’s books upon Agent's request at Agent's expense during normal business hours of Kallo.

iv.  

Kallo's failure to perform its duties in the event it becomes the controlling party of the Agent's Book of Business is a non-material breach of this agreement.

v.  

In any dispute or litigation over the terms of this agreement, the prevailing party shall have reasonable attorney fees in addition to any settlement or damages awarded.

d)  

Rights: Upon termination of this Agreement for any reason and unless otherwise agreed, all rights granted to Agent shall immediately cease and Agent shall immediately return to Kallo all Kallo Products and confidential information provided by Kallo except as otherwise provided in this Agreement.

e)  

No Compensation: In the event of an agreed termination of this Agreement by both parties, neither party shall be liable to the

a)  

Definition:  "Force Majeure" shall mean any event or condition not reasonably within the control of either party, which prevents in whole or in material part the performance by one of the parties of its obligations hereunder or which renders the performance of such obligations as difficult or costly as to make such performance commercially unreasonable.

b)  

Notice: Upon giving notice to the other party, a party affected by an event of Force Majeure shall be released without any liability on its part from the performance of its obligations under this Agreement, except for the obligation to pay any amounts due and owing hereunder, but only to the extent and only for the period that its performance of such obligations is prevented by the event of Force Majeure. The other party may likewise suspend the performance of all or part of its obligations hereunder to the extent that such suspension is commercially reasonable. Refer to Schedule B for available means of communication to all parties concerned

a)  

Rights: Kallo grants to Agent the non-exclusive and non-transferable right to distribute the use of the Kallo Mobile care suite of products to commercial end user customers. Refer to section (2) subparagraph (f) for non-exclusive and exclusive status and qualifying requirements.

b)  

Limitations: Agent shall distribute only Kallo Mobile care suite of products that Agent has obtained from Kallo and not from any other seller of the Kallo Mobile care suite of products. For Tax reasons such distribution is deemed to take place at the Agent’s business location identified above.

c)  

Pricing: The pricing given in Schedule A is the transfer price from Kallo to the Agent and the Agent shall, in its discretion establish a reasonable price for each of the Kallo Mobile care suite of products EULA as per Schedule A. For Maintenance Contract pricing and details refer to Schedule A, section (9), subparagraph (B). Kallo reserves the right to revise and republish prices as shown in Schedule A from time to time.

d)  

Payment terms: For each Kallo Mobile care suite of products license ordered by Agent from Kallo, Agent shall pay to Kallo the transfer price set forth in Schedule A. 50% of the total amount to be paid with the signed purchase order, 35% upon shipping of the goods to the carrier at Canadian port and 15% upon completion of the installation. Upon delivery of the system the Agent is responsible for getting the signed EULA from the customer before the installation process starts.

e)  

Taxes: All taxes from the country of origin and destination including customs duty, withholding taxes, any other levies – international / local and freight and insurance are to the end-user or customers account. The Agent will work with Kallo to add all applicable taxes to the pricing given in Schedule A and should be paid to Kallo along with the purchase order and the 50% of the value of the total system

a)  

Complete Agreement: This agreement and the provisions of the current   sales   agent program guidelines, as amended from time to time, constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all previous agreements by and between Kallo and agent as well as all proposals, oral or written and all prior negotiations, conversations or discussions between the parties related to this agreement. Agent acknowledges that it has not been induced to enter into this agreement by any representations or statements, oral or written, not expressly contained herein.

b)  

Amendment: This Agreement shall not be deemed or construed to be modified, amended, rescinded, cancelled or waived, in whole or in part, except by written amendment signed by the parties hereto. Refer to Schedule B for available means of communication to all parties concerned.

c)  

Unenforceability: If any provision of this Agreement is held to be invalid, illegal or unenforceable, such provision shall be considered severable from this Agreement and the remaining provisions shall continue in full force and effect. The parties will replace a severed provision by a provision, which is closest to the intent of the parties.

d)  

Notices:  Notices permitted or required to be given hereunder shall be deemed sufficient if given

i.  

by  registered  or  certified  mail, postage  prepaid,  return receipt requested, addressed to the addresses given in schedule B or such other addresses as the respective  parties  may  designate  by like  notice  from  time  to time, or

ii.  

by international courier, telefax to or by email, the details of which are given in Schedule B.

iii.  

Any notice shall be deemed effective when received by the receiving party.

e)  

Governing Law and Jurisdiction: The laws of the province of Ontario, Canada, govern this AGREEMENT and, in respect of any dispute, which may arise hereunder; Agent consents to the jurisdiction of the federal and provincial courts of Ontario, Canada.

f)  

Counterparts: This Agreement shall be executed in two or more counterparts in the English language and each such counterpart shall be deemed an original hereof.

g)  

Waiver: No failure by either party to take any action or assert any right hereunder shall be deemed to be a waiver of such right in the event of the continuation or repetition of the circumstances giving rise to such right.

h)  

Government:  If Agent is acting on behalf of any unit or agency of the United States Government, the following provisions apply:

i.  

any products Agent acquires under this Agreement for or on behalf of the United States Government are provided to the United States of America with restricted rights. Use, duplication, or disclosure by the U.S. Government is subject to restrictions as set forth in subparagraph  (c)(l)(ii) of the Rights in Technical Data and Computer Kallo Mobile care suite of products clause at DFARS ###-###-#### and paragraph (d) of the Commercial Computer Kallo Mobile care suite of products-Restricted Rights clause at FAR 52.227-19;

ii.  

Kallo grants Agent the right to transfer Kallo Mobile care suite of products to the United States government subject to the following restrictions. With the exception of the Department of Defense, you will not distribute the Kallo Mobile care suite of products to the United States of America except:

a.  

on terms at least as restrictive as those set forth in subparagraph (c)(l)(ii)  of the Rights in Technical Data and Computer Kallo Mobile care suite of products clause at DFARS ###-###-#### and paragraph (d) of the Commercial  computer  Kallo Mobile care suite of products -Restricted Rights clause at FAR 52.227-19, and

b.  

in compliance with particular department or agency acquisition  regulations  that  provide  Kallo protection  at  least equivalent  to that provided by the above-referenced DFARS and FAR provisions.

i)  

Export Restrictions: Agent expressly agrees to neither directly or through third parties export nor transmit any Kallo Mobile care suite of Products to any country to which such export or transmission is restricted or prohibited by applicable regulations or statutes, or any country other than the United States of America or Canada.

j)  

Non-Disparagement:  During the term hereof and for a period of two years thereafter, each of Agent and Kallo agrees that it will refrain from making any representation, statement, comment or any other form of communication, whether written or oral (hereinafter collectively referred to as a "Communication"), to any third party, including but not limited to the principals, customers, suppliers and competitors of the other party, which Communication reflects any opinion, judgment, observation or

a)  

Medications and medical consumables are not provided in the Mobile Medical Clinics and shall be provided at additional cost.

b)  

Auxiliary equipment for the Mobile Clinics:

i)  

Stretchers, backboards, collars, drugs, medications and other medical supplies can be provided at additional cost.

ii)  

All medical supplies to the government shall be on a contract supply based on demand, negotiated after the principal purchase order is placed for the Mobile Clinic.

A.  

Mobile Clinic and Command Center maintenance is included in the Five year Standard Mandatory Maintenance as per the Program description given in Schedule E

Attn:

Mr. John Cecil

Address:

15 Allstate Parkway, Suite #600

Markham, Ontario, L3R 5B4

Canada

Telephone:

+1 ###-###-####

Fax:

+1 ###-###-####

Email:

Attn:

Mr. Babajide A. Soyode

Address:

Motorways Centre Block 'B', Ground Floor 1

Motorways Avenue, Alausa,

Lagos, Nigeria.

Telephone:

+234 ###-###-####

Fax:

+

Email:

Attn:

Mr. Ajai Kunnath

Address:

GATEWAY GLOBAL FABRICATION LTD.

No-2 Olodu Street,

Off Oluobasanjo Road,

Portharcourt, Rivers state, Nigeria.

Address:

Gateway Canada.

147 Spring Gate Blvd.,

Thorn hill, Ontario, L4J 2B2

Tel:

+1 ###-###-####

Mobile:

+1 ###-###-####

Fax:

+

Email:

1.  

Customs clearance and delivery of Mobile Clinics.

2.  

Training of Client's Operations

3.  

Personnel of various cadres, doctors, nurses, paramedics, drivers, and medical technicians / technologists

4.  

Maintenance of medical equipment

5.  

Maintenance of the automobile and the engine of the Mobile Clinic and diesel generators

6.  

Procurement of communication channels such as satellite feed and high-speed internet connectivity for Command Centers

7.  

Provision of data acquisition and back-up storage systems

8.  

Supply of all local manpower, not provided by clients

9.  

Supply of residential accommodation, land transport, and general

10.  

Welfare amenities to all foreign personnel

11.  

Specialized IT and satellite communication support for Mobile Clinics

1.  

Letters of invitation to Kallo personnel for visas

2.  

Procurement of all import permits and licenses

3.  

Accommodation, welfare, and security arrangements

4.  

Arrangements for meetings with various organizations

5.  

Local transportation and security

6.  

Employment of local operational support staff, as required

1.  

Supply of Mobile Clinics and all operating equipment and software

2.  

Supply of all training personnel and materials for clinical staff (Doctors, Nurses and Front line Medical officers) and Biomedical Engineers and software Engineers.

3.  

Sourcing of backup foreign medical consultants, as required

4.  

Tele-health consulting for second opinion from medical specialists from US, Canada and UK

5.  

Procurement of all export permits and licenses

6.  

Supply of drugs/medications and spare parts during and after the warranty period.

1.  

Purchasing and transportation of Mobile Clinics, operating equipment, spare parts, medical consumables, drugs/medications to various distribution centers in Nigeria to replenish stocks in the Mobile Clinic, from Kallo Inc. Canada.

2.  

Customs clearance and inland transportation

3.  

Assistance with local market development and liaison with clients

1.  

All Parties in this agreement appoint BASCIC as Project manager without prejudice.

2.  

Project development, management and coordination

3.  

Liaison with Governments and clients and responsible for payments to Kallo and supply chain management of Medical consumables and medications/drugs from Kallo.

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

To retain Exclusivity for Nigeria

1.  

Planned and Corrective Maintenance

2.  

Calibration of Medical Equipment

3.  

Patient, Staff and Environment safety

4.  

Breakdown Services and Maintenance

5.  

Application and operation support

6.  

Risk Management

7.  

Codes and Standards adherence for International compliance

·  

requires no special sample preparation or user calibration; maintenance is minimal

·  

weighs 18 ounces, making it completely portable

·  

features ergonomically designed soft keys for comfort and ease of use

·  

The system prompts users step by step through the testing process

·  

Operator and patient information can be entered via barcode scanner

·  

Operator lockout prevents unauthorized users from performing or viewing test results

·  

Test results are uploaded automatically when the i-STAT handheld is placed in a downloader

·  

The Central Data Station System from Abbott Point of Care

·  

Abbott Diabetes Care PrecisionWeb®

·  

Medical Automation Systems RALS+™ RALS® Plus

·  

Telcor Quick-Linc®

·  

streamlines workflow

·  

helps reduce errors

·  

allows for increased efficiency

·  

facilitates compliance

·  

managing operator certification and device lockout

·  

reporting on operator performance

·  

reporting on both liquid and equivalent quality control

·  

reporting on reagent usage

·  

laboratory Information System interfacing

·  

The Analyzer is for in vitro use in the semi-quantitative detection of albumin, bilirubin, blood (occult), creatinine, glucose, ketone (acetoacetic acid), leukocytes, nitrite, pH, protein, specific gravity and urobilinogen in urine samples, depending on the type of Siemens urinalysis strip used.

·  

The semi-quantitative calculation of albumin-to-creatinine and protein-to-creatinine ratios in urine samples, when Clinitek® Microalbumin and Multistix PRO® Reagent Strips for Urinalysis are used.

·  

The detection of human Chorionic Gonadotropin (hCG) in urine samples, when Clinitest® hCG cassettes are used.

·  

Provides important markers to detect early stages of many disease states, such as diabetes, kidney disease and urinary tract infections.

·  

Enhances disease monitoring and patient management.

·  

Semi-quantitative results have proven to be cost-effective and virtually immediate.

•  

Canon CXDI-50RF Dynamic/Static Digital Radiography System 
The RadPRO D2RS Dynamic Digital Remote RF System is compatible with the Canon CXDI-50RF Dynamic/Static Digital Radiography System that includes a Cesium Iodide scintillator. Including both dynamic and static capabilities, high resolution images are produced and may be previewed within 2-4 seconds after exposure in the radiography mode with the optional monitor. The radiography mode produces up to 15 frames per second (fps), and up to 30 fps in the fluoroscopy mode, depending on the image capture mode and size. The detachable cable allows the digital detector to be used in multiple rooms or multiple locations within the same room.

•  

Dynamic and Static Imaging 
The Canon CXDI Control Software RF, designed specifically for the Canon CXDI-50RF Dynamic/Static Digital Radiography System, features a wide range of fluoroscopic procedures and includes all the standard DICOM functions. Exams include spine, Osteo-articular, Barium swallow and esophagus, stomach and small intestine, Barium enema and large bowel, Endoscopy/ERCP, Urography, Cystography, Hysterosalpingography, Myelography, Arthrography, Venography and more. The software also delivers high-resolution images, generator communication for preset X-ray parameters, provides actual exposure factors and patient dose information in the DICOM header. Studies that require full spine and long leg imaging are fully automated. With the automated stitching capability up to 4 images can be stitched together.

•  

High Quality Images 
High resolution static images can be previewed within 3-5 seconds after exposure on a monitor (optional). Images may be configured automatically with post-processing and are ready to be printed or transmitted through the network using industry standard DICOM protocols.

•  

Full Patient Coverage 
End-to-end table coverage is available when the motorized tube column angulation is combined with the motorized tube rotation. The motorized table adjusts the height, and the low minimum height simplifies access for patients with mobility issues. When patients arrive at the radiology room on a trolley or in a bed, Smart Access provides clear access to a 47 inch (120 cm) section of the table top to allow for a simplified transfer. The table loading capacity accommodates patients weighing up to 500 lbs (230 kg).

•  

Auto-Positioning 
Table movements, collimation and spectral filtration settings, exposure and digital acquisition parameters may be administered with the single touch, remote-controlled user-interface reducing the preparation time needed for exams.

•  

Non-Mydriatic Fundus Autofluorescence (FAF) Photography 
Fundus Autofluorescence (FAF) helps monitor macular waste (e.g. lipofuscin) which can accumulate in the Retinal Pigment Epithelial (RPE) layer. The accumulation of macular waste can cause conditions such as Age-Related Macular Degeneration (AMD) which can lead to reduced vision. The FAF mode may be selected by pressing only one button.

•  

Digital Filter Processing 
Red-Free and Cobalt digital filters are included and provide enhanced screening exams. Red-Free is used for evaluating the Retinal Nerve Fiber Layer (RNFL) and vascular structure of the retina associated with documenting Glaucoma, Diabetic Retinopathy or Hypertension. The Cobalt filter is also used for evaluating the RNFL, as well as Optic Disc and Optic Disc Drusen. Additionally, Green (Vascular view) and Red channel (Choroid view) digital filter views are also included.

•  

Compact and Lightweight 
The small design of the CR-2 PLUS facilitates portability when needed using an optional hard shell transport case sold separately. Canon instrument tables (sold separately) may comfortably fit both the camera and computer workstation (sold separately). The space saving design also allows for use in limited office space environments.

•  

Dedicated EOS Camera Technology 
High quality diagnostic images are obtained using a dedicated camera for the CR-2 PLUS which incorporates a large, high-definition CMOS sensor with 18 megapixels. When the camera cover is removed, the LCD may be adjusted to a variety of titled angles to suit the user's point of view.

•  

Low Flash Intensity and ISO Sensitivity 
The low flash intensity of the CR-2 PLUS minimizes miosis, thus shortening the time required for taking multiple view exams or stereo images. The reduced brightness improves patient comfort and reduces the "ghost" image the patient sees after an exposure. A wide range of low ISO speeds are supported including ISO 200, 400, 800, 1600, 3200 and 6400.

•  

Automatic Exposure Function 
The CR-2 PLUS measures the volume of infrared light from the retina and automatically adjusts the flash intensity for observation and photography. This feature may be set to ON/OFF and can be adjusted using the operation panel.

•  

Control Panel 
The simplified design of the control panel can be easily handled by an examiner. The one-handed joystick may be used to position the camera to acquire the desired image. In darkly lit rooms, the operation panel illuminates for easier navigation. The short main body of the CR-2 PLUS provides minimal distance between the patient and the operator allowing easy access to adjust the patient's position or eyelids.

•  

Retinal Imaging Control Software 
Using the Canon Retinal Imaging Control Software (RICS), images can be captured, viewed, processed, printed and saved to a permanent storage database. The Canon RICS complies with the DICOM®* Standard. Images may be stored as DICOM or JPEG files. For more information, visit Retinal Imaging Control Software.

·  

Acoustic Amplifier Technology

·  

Single Crystal Technology

·  

Matrix Array Technology

·  

Volume Hybrid Technology

 

 

·  

Compact and portable, easy to use

·  

Suitable for adult, pediatric and neonatal patients.

·  

Heart, Lung, Heart and Lung sound models for Stethoscope.

·  

Large color LCD display of ECG, SpO2 and Pulse rate

·  

Adjustable audible and visual alarms

·  

Real-time monitoring.24 hours storage and review of data

·  

SD card memory, all data can be transferred to a PC

·  

Low power consumption.

·  

Power Supply : Lithium Battery DC3.6~DC4.2V

·  

Display : 2.4" Color LCD

·  

Heart：20～230Hz

·  

Lung：100～800Hz

·  

H& L：20～800Hz

·  

Accuracy:± 2 bpm

·  

Measurement range: 30bpm～300bpm;

·  

Accuracy: ± 2 bpm

·  

Measurement range: 30bpm 250bpm;

·  

Accuracy: ± 2 bpm or ± 2%

·  

Measurement range: 35%～100%;

·  

Accuracy: 70~100% (± 2% )  <70% unspecified.

·  

Precise measurements

·  

Displays weight in either pounds or kilograms

·  

Memory recall with time/date stamp on select models

·  

Includes four attachable feet for carpet use

·  

Motion Tolerance Mode on select models

·  

Professional accuracy via oscillometric method

·  

Clinically validated

·  

One button operation

·  

Memory storage

·  

Provides time and date stamp

·  

Each monitor has unique serial number

·  

Meets ANSI/AAMI SP10 standards

·  

Provides immediate medication access – no more waiting or unnecessary trips.

·  

Enhances prescription fulfillment – resulting in greater patient compliance.

·  

System software/multiple barcode verifications virtually eliminate dispensing errors.